Atlas FDA

ClearView™ 3

FDA premarket approval P200020/S003 · decided 2023-02-17

Approval details

PMA number
P200020
Supplement
S003
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
ClearView™ 3
Generic name
Lens, multifocal intraocular
Applicant
Lenstec, Inc.
Date received
2022-12-15
Decision date
2023-02-17
Days to decision
64 days
Decision code
APPR
Product code
MFK
Advisory committee
Ophthalmic
Expedited review
No
Location
St. Petersburg, FL
Statement
Approval for the commercial name change from SBL-3 to ClearView 3.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Lenstec LC Injection system (K161776)Lenstec, Inc.2016-11-29
LENSTEC LC INJECTION SYSTEM (K122848)Lenstec, Inc.2013-10-18
FLUID ISOLATION DEVICE (K091915)Lenstec, Inc.2009-10-27
LENSTEC LC INJECTION SYSTEM (K063802)Lenstec, Inc.2007-05-07
LENSTEC INTRAOCULAR LENS (IOL) INJECTION SYSTEM (K060533)Lenstec, Inc.2006-04-14
LENSTEC INTRAOCULAR LENS (IOL) INJECTION SYSTEM FOR TETRAFLEX INTRAOCULAR LENSES (K050638)Lenstec, Inc.2005-05-31